Chemomab Therapeutics Ltd...
2.02
0.12 (6.32%)
At close: Jan 15, 2025, 10:14 AM

Chemomab Therapeutics Ltd. Statistics

Share Statistics

Chemomab Therapeutics Ltd. has 18.86M shares outstanding. The number of shares has increased by 38.42% in one year.

Shares Outstanding 18.86M
Shares Change (YoY) n/a
Shares Change (QoQ) 31.32%
Owned by Institutions (%) n/a
Shares Floating 16.57M
Failed to Deliver (FTD) Shares 49.41K
FTD / Avg. Volume 42.45%

Short Selling Information

The latest short interest is 162.90K, so 0.86% of the outstanding shares have been sold short.

Short Interest 162.90K
Short % of Shares Out 0.86%
Short % of Float 0.98%
Short Ratio (days to cover) 1.15

Valuation Ratios

The PE ratio is -0.25 and the forward PE ratio is -46.25.

PE Ratio -0.25
Forward PE -46.25
PS Ratio 0
Forward PS 1.5
PB Ratio 0.35
P/FCF Ratio -0.25
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Chemomab Therapeutics Ltd..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.32, with a Debt / Equity ratio of 0.

Current Ratio 4.32
Quick Ratio 4.32
Debt / Equity 0
Total Debt / Capitalization 0
Cash Flow / Debt 0
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is -1.43% and return on capital (ROIC) is -146.41%.

Return on Equity (ROE) -1.43%
Return on Assets (ROA) -1.09%
Return on Capital (ROIC) -146.41%
Revenue Per Employee 0
Profits Per Employee -1.21M
Employee Count 20
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by 246.15% in the last 52 weeks. The beta is 0.3, so Chemomab Therapeutics Ltd.'s price volatility has been higher than the market average.

Beta 0.3
52-Week Price Change 246.15%
50-Day Moving Average 1.74
200-Day Moving Average 1.32
Relative Strength Index (RSI) 49.68
Average Volume (20 Days) 116.40K

Income Statement

Revenue n/a
Gross Profit -66.83K
Operating Income -25.46M
Net Income -24.22M
EBITDA -25.39M
EBIT n/a
Earnings Per Share (EPS) -2.06
Full Income Statement

Balance Sheet

The company has 9.29M in cash and 392.00K in debt, giving a net cash position of 8.90M.

Cash & Cash Equivalents 9.29M
Total Debt 392.00K
Net Cash 8.90M
Retained Earnings -88.68M
Total Assets 20.90M
Working Capital 15.54M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -23.61M and capital expenditures -3.00K, giving a free cash flow of -23.61M.

Operating Cash Flow -23.61M
Capital Expenditures -3.00K
Free Cash Flow -23.61M
FCF Per Share -2.01
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CMMB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -108.99%
FCF Yield -66.26%
Dividend Details

Analyst Forecast

The average price target for CMMB is $7.5, which is 296.8% higher than the current price. The consensus rating is "Buy".

Price Target $7.5
Price Target Difference 296.8%
Analyst Consensus Buy
Analyst Count 2
Stock Forecasts

Stock Splits

The last stock split was on Mar 17, 2021. It was a backward split with a ratio of 1:16.

Last Split Date Mar 17, 2021
Split Type backward
Split Ratio 1:16

Scores

Altman Z-Score -2.19
Piotroski F-Score 2